Telephonic review for outpatients with epilepsy—A prospective randomized, parallel group study

Bahrani, Kunal; Singh, Mamta Bhushan; Bhatia, Rohit; Prasad, Kameshwar; Vibha, Deepti; Shukla, Garima; Vishnubhatla, Sreenivas; Patterson, Victor

doi:10.1016/j.seizure.2017.11.003

Cited by 80 publications

(72 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…19,20 The feasibility of telehealth in epilepsy care, including delivery of complex care to patients with refractory epilepsy, has similarly been demonstrated, with comparable outcome and high patient satisfaction. 13,[21][22][23] The lack of commensurate reimbursement has historically been the barrier to greater adoption. 24 Several early studies have examined the effect of transition to telehealth during the COVID-19 pandemic.…”

Section: Telehealthmentioning

confidence: 99%

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

et al. 2020

View full text Add to dashboard Cite

The COVID-19 pandemic has impacted the delivery of care to people with epilepsy (PWE) in multiple ways including limitations on in-person contact and restrictions on neurophysiological procedures. To better study the effect of the pandemic on PWE, members of the American Epilepsy Society were surveyed between April 30 and June 14, 2020. There were 366 initial responses (9% response rate) and 337 respondents remained for analysis after screening out noncompleters and those not directly involved with clinical care; the majority were physicians from the United States. About a third (30%) of respondents stated that they had patients with COVID-19 and reported no significant change in seizure frequency. Conversely, one-third of respondents reported new onset seizures in patients with COVID-19 who had no prior history of seizures. The majority of respondents felt that there were at least some barriers for PWE in receiving appropriate clinical care, neurophysiologic procedures, and elective surgery. Medication shortages were noted by approximately 30% of respondents, with no clear pattern in types of medication involved. Telehealth was overwhelmingly found to have value. Among the limitation of the survey was that it was administered at a single point in time in a rapidly changing pandemic. The survey showed that almost all respondents were affected by the pandemic in a variety of ways.

show abstract

Section: Telehealthmentioning

confidence: 99%

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

et al. 2020

View full text Add to dashboard Cite

show abstract

“…For all these patients, a simple phone call on their mobile phones may be an excellent way of consultation and follow up. 30 …”

Section: Management Of Epilepsy During Covid-19mentioning

confidence: 99%

Seizures and Epilepsy in Times of Corona Virus Disease 2019 Pandemic

Parihar¹,

Tripathi²,

Dhamija³

2020

J Epilepsy Res

View full text Add to dashboard Cite

The end of the year 2019 was marked by novel coronavirus (severe acute respiratory syndrome coronavirus-2, SARS-CoV-2) outbreak in China that rapidly spread to the rest of the world. While the involvement of the lower respiratory system causing pneumonia is identified as the primary target of the virus, extra-pulmonary manifestations, especially of the central nervous system, are also being increasingly reported. Previous research on Middle East respiratory syndrome coronavirus and SARS-CoV have shown neurological involvement in human coronavirus infections. While several cases of seizures have been reported in patients with coronavirus disease 2019 (COVID-19) patients, there is no specific data to suggest an association of COVID-19 with epilepsy. Epilepsy patients on immunosuppressive medications may have a higher risk of contracting the viral infection. There can be an indirect relation of COVID-19 to epilepsy as the viral infection is associated with fever in most COVID-19 cases, which can lower seizure threshold. Additionally, inadequate sleep and stress due to ongoing pandemic of coronavirus can be another trigger for seizure precipitation in epilepsy patients. Drug compliance, availability of antiepileptic drugs, and drug interactions with COVID-19 experimental drugs are major concerns in epilepsy patients. Adopting telemedicine services and the use of epilepsy helplines may be important in assisting epilepsy patients and ensuring that treatment continues uninterrupted.

show abstract

“…Many of these patients come from places, which are up to 1500-2000 kilometers away, and they belong to low middle to low socioeconomic status. In the past we have described how many of our epilepsy patients prefer and would be better served by the setting up of a telephonic follow-up system at least for some of them [11]. This may be another reminder to us that we could improve our epilepsy service significantly by setting up an option of telephonic review.…”

Section: Discussionmentioning

confidence: 99%

Comparing long-term outcomes of epilepsy patients from a single-visit outreach clinic with a conventional epilepsy clinic: A cross-sectional observational study from India

Prajapati

Singh

Srivastava

et al. 2019

Seizure

Self Cite

View full text Add to dashboard Cite

A B S T R A C TPurpose: To compare long-term treatment outcomes in epilepsy patients from a single-visit outreach clinic on the Lifeline Express (LLE) with a conventional hospital (AIIMS) based epilepsy clinic in India. Methods: Using a cross-sectional observational study design, consecutive epilepsy patients from fifteen LLE clinics conducted from 2009 to 2014 were compared to epilepsy patients registered in the same duration at the AIIMS epilepsy clinic. The primary outcome was to determine if patients were still taking AEDs. To determine current AED status, patients from the LLE clinic were contacted telephonically. For the AIIMS patients, hospital records were reviewed and phone calls made to those patients who had not followed-up for more than a year. Results: In the 5 years under review, 1923 and 1257 patients had consulted at the LLE and AIIMS clinics respectively. Long-term outcomes were available for analysis in 688 AIIMS and 531 LLE clinic patients. Of the AIIMS patients, 581(87%) were continuing AEDs, 49(7%) had discontinued AEDs after being seizure-free for at least 5 years, 39(6%) had discontinued AEDs without medical advice and 19(2.8%) were dead. Outcomes in 531 LLE patients revealed that 351(72%) continued to be on AEDs, 34(7%) had discontinued AEDs on advice, 106 (22%) had discontinued AEDs without any medical advice and 40 (7.5%) were dead. The treatment gap in the LLE patients was reduced from 49% at first contact to 22% at follow-up 2-8 years later. Conclusions: Even single-visit epilepsy clinics may be an effective option for reducing treatment gap in limitedresource regions of the world.

show abstract

Telephonic review for outpatients with epilepsy—A prospective randomized, parallel group study

Cited by 80 publications

References 6 publications

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

Seizures and Epilepsy in Times of Corona Virus Disease 2019 Pandemic

Comparing long-term outcomes of epilepsy patients from a single-visit outreach clinic with a conventional epilepsy clinic: A cross-sectional observational study from India

Contact Info

Product

Resources

About